Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most common neoplasm that occurs in the kidney and is marked by a unique biology, with a long history of poor response to conventional cancer treatments. In the past few years, there have been significant advancements to understand the biology of RCC. This has led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Ashutosh, Semwal, Deepak Kumar, Mishra, Satyendra Prasad, Goyal, Sandeep, Marathe, Rajendra, Semwal, Ruchi Badoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635794/
https://www.ncbi.nlm.nih.gov/pubmed/29083380
http://dx.doi.org/10.3390/medsci4040016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635794/
https://www.ncbi.nlm.nih.gov/pubmed/29083380
http://dx.doi.org/10.3390/medsci4040016

Ejemplares similares